Table 3.

CAFC Survival 24 Hours After 5-FU/KL Ablation

TreatmentNo. of Weekly CyclesCAFC Survival
CAFC-7/HL(%)CAFC-28/HL(%)
Saline 81,592 (61,131-108,901)ρ 100 1,939 (1,427-2,634) 100 
5-FU 2,258 (1,540-3,309) 2.8 (1.9-4.1) 1,164 (797-1,699) 60 (41-88) 
5-FU 2,827 (2,158-3,702) 3.5 (2.6-4.5) 952 (715-1,266) 49 (37-65) 
5-FU + KL3-150 2,116 (1,433-3,126) 2.6 (1.8-3.8) 885 (557-1,408) 45.6 (28.7-72.6) 
5-FU + KL3-151  127 (87-187) 0.16 (0.11-0.23) 263 (179-385) 13.6 (9.2-19.9) 
5-FU + KL3-150  51 (39-66) 0.06 (0.05-0.08) 192 (148-250) 9.9 (7.6-12.9) 
5-FU + KL + G-CSF3-152 23.4 (13.0-42.1) 0.03 (0.02-0.05) 319 (217-467) 16.4 (11.2-24.1) 
TreatmentNo. of Weekly CyclesCAFC Survival
CAFC-7/HL(%)CAFC-28/HL(%)
Saline 81,592 (61,131-108,901)ρ 100 1,939 (1,427-2,634) 100 
5-FU 2,258 (1,540-3,309) 2.8 (1.9-4.1) 1,164 (797-1,699) 60 (41-88) 
5-FU 2,827 (2,158-3,702) 3.5 (2.6-4.5) 952 (715-1,266) 49 (37-65) 
5-FU + KL3-150 2,116 (1,433-3,126) 2.6 (1.8-3.8) 885 (557-1,408) 45.6 (28.7-72.6) 
5-FU + KL3-151  127 (87-187) 0.16 (0.11-0.23) 263 (179-385) 13.6 (9.2-19.9) 
5-FU + KL3-150  51 (39-66) 0.06 (0.05-0.08) 192 (148-250) 9.9 (7.6-12.9) 
5-FU + KL + G-CSF3-152 23.4 (13.0-42.1) 0.03 (0.02-0.05) 319 (217-467) 16.4 (11.2-24.1) 
F3-150

KL = 50 μg/kg/dose.

F3-151

KL = 12.5 μg/kg/dose.

F3-152

KL = 12.5 μg/kg/dose; G-CSF = 100 μg/kg/dose.

ρ Mean with 95% confidence interval range in parentheses.

or Create an Account

Close Modal
Close Modal